REPLICEL LIFE SCIENCES INC. Profit Loss From Operating Activities
REPLICEL LIFE SCIENCES INC. reported Profit Loss From Operating Activities of -CAD 1.40 million for the 12-month period ending 2022-12-31, per its 20-F filed 2023-05-02.
Discontinued › Cash Flow › Operating Activities
ifrs-full:ProfitLossFromOperatingActivities · last filed 2023-05-02
| Period end | Profit Loss From Operating Activities 12 month | Profit Loss From Operating Activities 12 month as first filed |
|---|---|---|
| 2022-12-31 | -1.40M CAD 20-F · filed 2023-05-02 | |
| 2021-12-31 | -2.30M CAD 20-F · filed 2023-05-02 | |
| 2020-12-31 | -1.35M CAD 20-F · filed 2023-05-02 | |
| 2019-12-31 | -2.93M CAD 20-F/A · filed 2022-09-13 | -3.02M CAD 20-F · filed 2020-08-05 |
| 2018-12-31 | -2.70M CAD 20-F · filed 2021-05-17 | -2.74M CAD 20-F · filed 2019-04-30 |
| 2017-12-31 | -5.99M CAD 20-F/A · filed 2021-03-31 | |
| 2016-12-31 | -4.29M CAD 20-F · filed 2019-04-30 | |
| 2015-12-31 | -5.05M CAD 20-F · filed 2018-05-11 |